Browse Pet Safety Reports
8,562 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 8,562 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 8,562 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 15, 2021 | Dog | Boxer (German Boxer) | Oclacitinib Maleate | Pododermatitis | Ongoing |
| Feb 14, 2021 | Dog | Shepherd Dog - German, Terr... | Carprofen | Moist dermatitis; Limping; Swollen limb; Skin disorders NOS | Ongoing |
| Feb 10, 2021 | Dog | Cattle Dog - Australian (bl... | Melarsomine Dihydrochloride | Suppurative dermatitis | Ongoing |
| Feb 9, 2021 | Dog | Spitz - German Pomeranian | Imidacloprid; Moxidectin | Vomiting; Diarrhoea; Moist dermatitis; Skin swelling; Decreased appetite; Ten... | Recovered/Normal |
| Feb 6, 2021 | Dog | Shepherd Dog - Australian | Moxidectin | Diarrhoea; Lethargy (see also Central nervous system depression in 'Neurologi... | Ongoing |
| Feb 4, 2021 | Cat | Domestic Shorthair | Cefovecin | Hot spot (pyotraumatic dermatitis); Application site lesion | Ongoing |
| Feb 3, 2021 | Dog | Bulldog - French | Milbemycin Oxime; Praziquantel | Regurgitation; Dermatitis; Otitis externa; Cardiac disorder NOS | Ongoing |
| Feb 1, 2021 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Hot spot (pyotraumatic dermatitis); Pruritus; Reddening of the skin | Outcome Unknown |
| Feb 1, 2021 | Dog | Schnauzer - Miniature | Spinosad; Milbemycin Oxime | Hot spot (pyotraumatic dermatitis); Facial swelling (see also 'Skin'); UNPALA... | Recovered/Normal |
| Feb 1, 2021 | Dog | Poodle - Standard | Sarolaner | Pruritus; Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| Jan 30, 2021 | Dog | Great Pyrenees | Florfenicol; Terbinafine Hydrochlorid... | Ear pain; Ear canal inflammation; Moist dermatitis; Behavioural disorder NOS;... | Recovered/Normal |
| Jan 28, 2021 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Itching; Scratching; Excessive licking and/or grooming; Lethargy (see also Ce... | Ongoing |
| Jan 23, 2021 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Scratching; Application site hair loss; Application site dermatitis; Applicat... | Ongoing |
| Jan 23, 2021 | Cattle | Holstein-Friesian also know... | Eprinomectin | Application site alopecia; Contact dermatitis; Other abnormal test result NOS | Recovered with Sequela |
| Jan 20, 2021 | Cat | Domestic Shorthair | Mirtazapine | Application site reddening; Application site dermatitis; Application site cru... | Outcome Unknown |
| Jan 20, 2021 | Cat | Cat (unknown) | Mirtazapine | Application site reddening; Application site crust; Application site dermatitis | Recovered/Normal |
| Jan 11, 2021 | Dog | Shepherd Dog - Australian, ... | Trilostane | Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| Jan 11, 2021 | Dog | Poodle - Miniature | Carprofen | Injection site hair loss; Injection site reaction NOS; Injection site pannicu... | Ongoing |
| Jan 4, 2021 | Dog | Dog (other) | Milbemycin/Lufenuron Tablets | Face and neck swelling (see also 'Skin'); Hot spot (pyotraumatic dermatitis);... | Ongoing |
| Jan 4, 2021 | Dog | Shepherd (unspecified), Dog... | Enrofloxacin | Face and neck swelling (see also 'Skin'); Hot spot (pyotraumatic dermatitis) | Ongoing |
| Jan 4, 2021 | Dog | Crossbred Canine/dog | Spinosad; Milbemycin Oxime | Allergic reaction; Allergic dermatitis; Lack of efficacy (endoparasite) - hea... | Outcome Unknown |
| Jan 2, 2021 | Dog | Dachshund - Miniature, Dog ... | Carprofen | Behavioural disorder NOS; Crust; Bruising; Erythema (for urticaria see Immune... | Outcome Unknown |
| Jan 1, 2021 | Dog | Dog (unknown) | Spinosad; Milbemycin Oxime | Dermatitis | Outcome Unknown |
| Jan 1, 2021 | Dog | Retriever - Golden | Desoxycortone | Hip dysplasia; Arrhythmia; Moist dermatitis; Collapse (see also 'Cardio-vascu... | Ongoing |
| Jan 1, 2021 | Dog | Crossbred Canine/dog | Carprofen | Urinary incontinence; Polyuria; Polydipsia; Panting; Abnormal dexamethasone s... | Ongoing |
| Jan 1, 2021 | Dog | Shepherd Dog - German | Imidacloprid; Moxidectin | Reddening of the skin; Dermatitis | Outcome Unknown |
| Dec 29, 2020 | Dog | Great Pyrenees | Melarsomine Dihydrochloride | Injection site abscess; Injection site dermatitis | Recovered/Normal |
| Dec 28, 2020 | Dog | Terrier - Bull - American Pit | Oclacitinib Maleate | Localised skin reaction; Skin and/or appendage neoplasm NOS; Dermatitis | Recovered/Normal |
| Dec 22, 2020 | Dog | Poodle - Standard | Cefovecin | Blistering (see also Application site SOC); Ulcerative dermatitis | Ongoing |
| Dec 15, 2020 | Dog | Dog (unknown) | Milbemycin Oxime; Praziquantel | Dermatitis | Outcome Unknown |
| Dec 7, 2020 | Dog | Boxer (German Boxer) | Enrofloxacin | Injection site necrosis; Injection site scab; Other abnormal test result NOS;... | Outcome Unknown |
| Dec 4, 2020 | Dog | Pit Bull | Ivermectin; Pyrantel As Pamoate Salt | Papular rash; Greasy skin; Skin lesion NOS; Pododermatitis; Erythematous rash... | Ongoing |
| Dec 3, 2020 | Dog | Terrier - Boston | Trilostane | Dermatitis; Pyoderma; Skin scab; Lack of efficacy - NOS; Weight loss; Cutaneo... | Outcome Unknown |
| Dec 3, 2020 | Dog | Shepherd Dog - Australian | Spinosad; Milbemycin Oxime | Lack of efficacy (endoparasite) - heartworm; Dermatitis | Outcome Unknown |
| Dec 2, 2020 | Dog | Shepherd Dog - German, Rott... | Ivermectin; Pyrantel As Pamoate Salt | Erythema (for urticaria see Immune SOC); Itching; Skin swelling; Other ear di... | Recovered/Normal |
| Dec 1, 2020 | Dog | Lhasa Apso, Poodle (unspeci... | Oclacitinib Maleate | Ulceration NOS; Vulvar oedema; Gingival erythema; Dermatitis | Ongoing |
| Nov 30, 2020 | Dog | Shiba Inu | Florfenicol; Terbinafine Hydrochlorid... | Twitching; Stumbling gait; Anorexia; Deafness; Ataxia; Polyuria; Inappropriat... | Outcome Unknown |
| Nov 23, 2020 | Dog | Terrier - Boston | Desoxycorticosterone Pivalate | Limping; Head tremor; Difficulty to rise; Malaise; Muscle atrophy (see also '... | Ongoing |
| Nov 22, 2020 | Dog | Dog (other) | Melarsomine Dihydrochloride | Hot spot (pyotraumatic dermatitis); Pancytopenia; Thrombocytopenia | Outcome Unknown |
| Nov 21, 2020 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site dermatitis; Application site scratching; Application site sore | Ongoing |
| Nov 20, 2020 | Dog | Crossbred Canine/dog | Maropitant Citrate | Facial swelling (see also 'Skin'); Facial oedema; Shaking; Vomiting; Decrease... | Ongoing |
| Nov 19, 2020 | Dog | Retriever - Labrador | Melarsomine Dihydrochloride | Hives (see also 'Skin'); General hair loss; Dermatitis | Outcome Unknown |
| Nov 18, 2020 | Dog | Bullmastiff | Oclacitinib Maleate | Fungal skin infection NOS; Pododermatitis | Ongoing |
| Nov 12, 2020 | Dog | Boxer (German Boxer), Pit Bull | Afoxolaner | Erythema (for urticaria see Immune SOC); Skin scab; Dermal mass; Pruritus; Ho... | Outcome Unknown |
| Nov 10, 2020 | Dog | Pit Bull | Spinosad; Milbemycin Oxime | Dermatitis; Vomiting | Ongoing |
| Nov 2, 2020 | Dog | Bulldog | Imidacloprid; Moxidectin | Application site dermatitis | Outcome Unknown |
| Nov 1, 2020 | Dog | Shepherd Dog - German | Grapiprant | Dermatitis; Low platelet count; Elevated alanine aminotransferase (ALT) | Outcome Unknown |
| Nov 1, 2020 | Cat | Ragdoll | Fluralaner/Moxidectin Spot-On | Application site alopecia; Application site dermatitis | Ongoing |
| Oct 28, 2020 | Dog | Chihuahua | Fluralaner 13.64% 12-Week Chew | Lethargy (see also Central nervous system depression in 'Neurological'); Inap... | Euthanized |
| Oct 23, 2020 | Dog | Dog (unknown) | Cyclosporine | Dermatitis; Pruritus | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.